Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.
about
Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patientsThalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.Cecropin-P17, an analog of Cecropin B, inhibits human hepatocellular carcinoma cell HepG-2 proliferation via regulation of ROS, Caspase, Bax, and Bcl-2.Dahuang Zhechong Pill Combined with Doxorubicin Induces Cell Death through Regulating Energy Metabolism in Human Hepatocellular Carcinoma Cells.Immunomodulation in hepatocellular cancer.
P2860
Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular targeting agents ass ...... in hepatocarcinoma treatment.
@en
Molecular targeting agents ass ...... in hepatocarcinoma treatment.
@nl
type
label
Molecular targeting agents ass ...... in hepatocarcinoma treatment.
@en
Molecular targeting agents ass ...... in hepatocarcinoma treatment.
@nl
prefLabel
Molecular targeting agents ass ...... in hepatocarcinoma treatment.
@en
Molecular targeting agents ass ...... in hepatocarcinoma treatment.
@nl
P2093
P2860
P356
P1476
Molecular targeting agents ass ...... in hepatocarcinoma treatment.
@en
P2093
Angelo Paradiso
Cosmo Damiano Gadaleta
Girolamo Ranieri
Ilaria Marech
Veronica Goffredo
Vito Lorusso
P2860
P304
P356
10.3748/WJG.V20.I2.486
P407
P577
2014-01-01T00:00:00Z